[Retracted] In Silico Structural and Functional Analyses of NLRP3 Inflammasomes to Provide Insights for Treating Neurodegenerative Diseases
BioMed Research International · 2023
DOI: 10.1155/2023/9819005 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift BioMed Research International, 2023. Verfasst von Behram Khan Ghazi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Punjab Medical College, Faisalabad, Pakistan. Hauptthemen laut MEDLINE: Inflammasomes, Neurodegenerative Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Inflammasomes are cytoplasmic intracellular multiprotein complexes that control the innate immune system’s activation of inflammation in response to derived chemicals. Recent advancements increased our molecular knowledge of activation of NLRP3 inflammasomes. Although several studies have been done to investigate the role of inflammasomes in innate immunity and other diseases, structural, functional, and evolutionary investigations are needed to further understand the clinical consequences of NLRP3 gene. The purpose of this study is to investigate the structural and functional impact of the NLRP3 protein by using a computational analysis to uncover putative protein sites involved in the stabilization of the protein‐ligand complexes with inhibitors. This will allow for a deeper understanding of the molecular mechanism underlying these interactions. It was found that human NLRP3 gene coexpresses with PYCARD, NLRC4, CASP1, MAVS, and CTSB based on observed coexpression of homologs in other species. The NACHT, LRR, and PYD domain‐containing protein 3 is a key player in innate immunity and inflammation as the sensor subunit of the NLRP3 inflammasome. The inflammasome polymeric complex, consisting of NLRP3, PYCARD, and CASP1, is formed in response to pathogens and other damage‐associated signals (and possibly CASP4 and CASP5). Comprehensive structural and functional analyses of NLRP3 inflammasome components offer a fresh approach to the development of new treatments for a wide variety of human disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Punjab Medical College, Faisalabad, Pakistan.
- Basic Health Unit, 14/8R Khanewal, Pakistan.
- Rural Health Centre 6/G, Chishtian, Bahawalnagar, Pakistan.
- Department of Animal Science, College of Dryland Agriculture, Samara University, Ethiopia.
- Services Institute of Medical Sciences, Lahore, Pakistan.
- Acute & Specialty Medicine Hospital Epsom & St. Helier University Hospitals NHS Trust Medical College, Faisalabad Medical University, Pakistan.
ORCID-Profile: Behram Khan Ghazi, Shishay Girmay
Förderung
- King Saud University
Zitieren
APA
Ghazi, B. K., Bangash, M. H., Razzaq, A. A., Kiyani, M., Girmay, S., Chaudhary, W. R., Zahid, U., Hussain, U., Mujahid, H., Parvaiz, U., Buzdar, I. A., Nawaz, S., & Elsadek, M. F. (2023). [Retracted] In Silico Structural and Functional Analyses of NLRP3 Inflammasomes to Provide Insights for Treating Neurodegenerative Diseases. BioMed Research International. https://doi.org/10.1155/2023/9819005
Vancouver
Ghazi BK, Bangash MH, Razzaq AA, Kiyani M, Girmay S, Chaudhary WR, et al. [Retracted] In Silico Structural and Functional Analyses of NLRP3 Inflammasomes to Provide Insights for Treating Neurodegenerative Diseases. BioMed Research International. 2023. doi:10.1155/2023/9819005
BibTeX
@article{Ghazi2023,
author = {Ghazi, Behram Khan and Bangash, Maria Hussain and Razzaq, Anam Abdul and Kiyani, Madiha and Girmay, Shishay and Chaudhary, Waleed Razzaq and Zahid, Usman and Hussain, Uzma and Mujahid, Huma and Parvaiz, Usama and Buzdar, Irfan Ahmed and Nawaz, Shah and Elsadek, Mohamed Farouk},
title = {[Retracted] In Silico Structural and Functional Analyses of NLRP3 Inflammasomes to Provide Insights for Treating Neurodegenerative Diseases},
journal = {BioMed Research International},
year = {2023},
doi = {10.1155/2023/9819005}
}
EUVIMED